Lonza is poised for growth amid margin recovery, onshoring opportunities, and strong profit projections. Read more on LZAGY ...

Lonza Group AG / Key word (s): Miscellaneous Lonza Implements its Simplified and Streamlined Operating Model 01.04.2025 / 14:00 CET/CEST ...

Lonza, the Swiss Biotech firm that purchased Vacaville’s Genentech plant from Roche in 2024, released a streamlined operating model and invitations to its Annual General Meeting in Basel, ...

Lonza Group AG / Key word (s): Share Buyback Lonza Completes its Share Buyback Program 01.04.2025 / 07:00 CET/CEST ...

Full Year 2024 Results Key Financial Results Revenue: CHF6.57b (down 2.1% from FY 2023).

O n Wednesday, Morgan Stanley (NYSE:MS) analysts adjusted their stance on Lonza Group (LONN:SW) (OTC: LZAGY), downgrading the stock from Overweight to Equalweight, while increasing the price ...

Lonza Group posted lower sales and earnings in 2024 due to slower demand for its capsules business which it expects to return to growth this year. The Swiss life-sciences company said Wednesday ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

To get a sense of who is truly in control of Lonza Group AG (VTX:LONN), it is important to understand the ownership structure of the business. We can see that individual investors own the lion's ...

Lonza Group Ltd (LZAGF) reports stable revenue, robust cash flow, and outlines ambitious growth plans for 2025 amidst market challenges. The Lonza CEO said the company is not under any pressure to ...

Annual Results/Sustainability Lonza Publishes Invitation to the 2025 Annual General Meeting and 2024 Annual and Sustainability Reports 03-Apr-2025 / 07:00 CET/CEST Release ...

Lonza has announced its new streamlined operating model, effective today. Lonza’s new One Lonza vision and strategy, centered ...